查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1801305

全球分子診斷市場：產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 225 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2025 年全球分子診斷市場價值將達到 252 億美元，到 2032 年將達到 434 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

分子診斷透過分析基因組和蛋白質組中的生物標記來診斷和監測疾病、檢測風險並確定每位患者最合適的治療方法。由於其準確性、速度和個人化治療的潛力，該領域在臨床實踐中變得越來越重要。分子診斷市場涵蓋PCR、NGS、微陣列和原位雜合反應等技術，廣泛應用於醫院、診斷實驗室、研究機構和居家醫療機構。市場擴張的驅動力包括：對早期疾病檢測日益成長的需求、感染疾病和慢性病的日益普及以及分子技術的持續創新。

市場促進因素

全球分子診斷市場受多種關鍵因素驅動，包括新冠肺炎 (COVID-19)、愛滋病毒 (HIV)、肝炎和結核病等感染疾病負擔的不斷加重。此外，對個人化醫療和標靶治療的日益重視也推動了對精準分子檢測的需求。照護現場)的日益普及，以及伴隨診斷在腫瘤學中的廣泛應用，進一步推動了需求成長。自動化、即時PCR和次世代定序技術的進步，正在提高診斷效率、速度和靈敏度，擴大其在整個醫療保健系統中的市場應用。

市場限制

儘管成長前景光明，分子診斷市場仍面臨設備和檢測成本高等挑戰，尤其是在中低收入國家。報銷限制（尤其是新型診斷工具的報銷限制）限制了其可近性。複雜的監管和冗長的核准流程也對創新和市場准入構成了障礙。此外，在資源有限的環境中，熟練實驗室專業人員的短缺和基礎設施的限制也阻礙了先進分子診斷技術的推廣。

市場機會

由於分子診斷在腫瘤學、基因檢測、藥物基因組學和感染疾病管理等領域的應用不斷擴展，該市場蘊含著巨大的成長機會。人工智慧與生物資訊學在數據分析領域的融合正在改變診斷領域。科學研究投入的增加以及公私合營的加強，正在推動尖端分子偵測的創新和商業化。人們對早期疾病檢測意識的提升以及醫療保健支出的不斷成長（尤其是在新興市場），預計將為市場擴張開闢新的途徑。此外，可攜式、易於使用的就地檢驗分子診斷套件的開發，有望徹底改變都市區和偏遠地區的患者照護。

本報告研究了全球分子診斷市場，按產品類型、疾病領域、最終用途和地理趨勢進行細分，並介紹了參與市場的公司概況。

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 價值鏈分析
  • 宏觀經濟因素
  • 預測因子－相關性和影響力
  • COVID-19影響評估
  • PESTLE分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 監管和技術格局

第3章 市場動態

  • 驅動程式
  • 抑制因素
  • 機會
  • 趨勢

第4章 2019-2032年價格趨勢分析

  • 區域價格分析
  • 按細分市場定價
  • 價格影響因素

第5章全球分子診斷市場展望：實際情況（2019-2024 年）與預測（2025-2032 年）

  • 主要亮點
  • 全球分子診斷市場按產品類型展望
    • 簡介/主要發現
    • 2019-2024 年產品類型市場規模趨勢分析
    • 2025 年至 2032 年按產品類型分類的當前市場規模預測
      • 裝置
        • 聚合酵素鏈鎖反應（PCR）系統
        • 雜合反應（原位雜合反應和FISH）系統
        • DNA定序與次世代定序平台
        • 微陣列
      • 試劑
        • 抗體
        • DNA模板
        • DNA聚合酵素
        • 寡核苷酸引子
        • 脫氧核糖核苷酸三磷酸（dNTP）
        • 緩衝
      • 檢測試劑套件
      • 耗材
    • 按產品類型進行的市場吸引力分析
  • 全球分子診斷市場按治療領域展望
    • 簡介/主要發現
    • 2019-2024年按疾病領域分類的市場規模趨勢分析
    • 2025 年至 2032 年按治療領域分類的當前市場規模預測
      • 感染疾病
      • 糖尿病
      • 心臟病學
      • 腫瘤學
      • 腎臟病學
      • 自體免疫疾病
      • 皮膚科
      • 創傷護理
      • 其他
    • 依治療領域分析市場吸引力
  • 全球分子診斷市場展望（按最終用途）
    • 簡介/主要發現
    • 2019-2024 年按最終用途分類的市場規模分析
    • 2025 年至 2032 年按最終用途分類的當前市場規模預測
      • 醫院和診所
      • 診斷實驗室
      • 學術研究機構
      • 生物製藥公司
    • 依最終用途進行市場吸引力分析

第6章 全球分子診斷市場（按地區）展望

  • 主要亮點
  • 2019-2024 年各地區市場規模趨勢分析
  • 2025 年至 2032 年各地區目前市場規模預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分析市場吸引力

第7章北美分子診斷市場展望：實際（2019-2024）與預測（2025-2032）

第8章 歐洲分子診斷市場展望：實際情況（2019-2024 年）與預測（2025-2032 年）

第9章東亞分子診斷市場展望：實際（2019-2024）與預測（2025-2032）

第 10 章南亞和大洋洲分子診斷市場展望：實際（2019-2024 年）和預測（2025-2032 年）

第 11 章拉丁美洲分子診斷市場展望：實際（2019-2024 年）和預測（2025-2032 年）

第 12 章。中東和非洲分子診斷市場展望：實際（2019-2024 年）和預測（2025-2032 年）

第13章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
  • 公司簡介
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories In
    • Merck KgaA
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • F. Hoffman-La Roche Ltd.
    • Illumina, Inc.
    • Qiagen NV
    • Hologic Inc.
    • Siemens Healthineers AG
    • Seegene, Inc.
    • DiaSorin SpA
    • Grifols, SA
    • bioMerieux
    • QuidelOrtho Corporation

第14章 附錄

簡介目錄
Product Code: PMRREP2784

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
  • Projected Market Value (2032F): USD 43.4 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.1%

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics involves the analysis of biological markers in the genome and proteome to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients. This segment has become increasingly essential in clinical practice due to its accuracy, speed, and potential for personalization of treatment. The molecular diagnostics market serves hospitals, diagnostic laboratories, research institutes, and homecare settings, encompassing technologies like PCR, NGS, microarrays, and in situ hybridization. Market expansion is being driven by rising demand for early disease detection, increased prevalence of infectious and chronic diseases, and continuous innovations in molecular technologies.

Market Growth Drivers:

The global molecular diagnostics market is propelled by several key factors, including the rising burden of infectious diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Additionally, the growing emphasis on personalized medicine and targeted therapies necessitates accurate molecular testing. The increasing use of point-of-care diagnostics, along with the proliferation of companion diagnostics in oncology, further enhances the demand. Technological advancements in automation, real-time PCR, and next-generation sequencing are improving diagnostic efficiency, speed, and sensitivity, thereby expanding market adoption across healthcare systems.

Market Restraints:

Despite promising growth, the molecular diagnostics market faces certain challenges, such as high cost of instruments and tests, especially in low- and middle-income countries. Reimbursement limitations, particularly for novel diagnostic tools, restrict accessibility. Regulatory complexities and time-consuming approval processes also act as barriers to innovation and market entry. Furthermore, the shortage of skilled laboratory professionals and infrastructure constraints in resource-limited settings hinder the adoption of advanced molecular diagnostics.

Market Opportunities:

The molecular diagnostics market presents significant growth opportunities fueled by expanding applications in oncology, genetic testing, pharmacogenomics, and infectious disease management. The integration of artificial intelligence and bioinformatics for data analysis is transforming the diagnostic landscape. Increasing investments in research and public-private collaborations are promoting innovation and commercialization of cutting-edge molecular tests. Growing awareness about early disease detection and rising healthcare spending, especially in emerging markets, are expected to unlock new avenues for market expansion. Additionally, the development of portable and easy-to-use molecular diagnostic kits for point-of-care testing is set to revolutionize patient care in both urban and remote areas.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the molecular diagnostics market globally?
  • Which technologies and applications are most widely adopted in clinical molecular diagnostics?
  • How are emerging technologies like NGS and AI impacting the competitive landscape?
  • Who are the leading companies in the molecular diagnostics market, and what strategies are they using to stay competitive?
  • What are the key trends and future outlook for the global molecular diagnostics market?

Competitive Intelligence and Business Strategy:

These companies focus on expanding their test portfolios, developing multiplex and syndromic testing panels, and enhancing automation and throughput of diagnostic systems. Collaborations with biotechnology firms, diagnostic labs, and healthcare institutions drive access and adoption. Furthermore, companies are prioritizing regulatory approvals, market expansion in developing economies, and customer-centric strategies to reinforce their global presence.

Key Companies Profiled:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories In
  • Merck KgaA
  • Thermo Fisher Scientific Inc
  • Agilent Technologies, Inc.
  • F. Hoffman - La Roche Ltd.
  • Illumina, Inc.
  • Qiagen N.V.
  • Hologic Inc.
  • Siemens Healthineers AG
  • Seegene, Inc.
  • DiaSorin S.p.A
  • Grifols, S.A.
  • bioMerieux
  • QuidelOrtho Corporation
  • RapidBio
  • Abbott Laboratories
  • Danaher Corporation

Molecular Diagnostics Market Research Segmentation:

By Product Type:

  • Instruments
    • * Polymerase Chain Reaction (PCR) Systems
    • * Hybridization (In-Situ Hybridization & Fish) Systems
    • * DNA Sequencing and Next-Generation Sequencing Platforms
    • * Microarrays
  • Reagent
    • * Antibodies
    • * DNA Template
    • * DNA Polymerase
    • * Oligonucleotide Primers
    • * Deoxyribonucleotide Triphosphate (dNTPs)
    • * Buffer
  • Assay Kits
  • Consumables

By Disease Area:

  • Infectious Disease
  • Diabetes
  • Cardiology
  • Oncology
  • Nephrology
  • Autoimmune Disease
  • Dermatology
  • Wound Care
  • Others

By End-use:

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Academic and Research Institutes
  • Biopharmaceutical Companies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Molecular Diagnostics Market Outlook: Product Type
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
    • 5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
      • 5.2.3.1. Instruments
        • 5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
        • 5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
        • 5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
        • 5.2.3.1.4. Microarrays
      • 5.2.3.2. Reagent
        • 5.2.3.2.1. Antibodies
        • 5.2.3.2.2. DNA Template
        • 5.2.3.2.3. DNA Polymerase
        • 5.2.3.2.4. Oligonucleotide Primers
        • 5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
        • 5.2.3.2.6. Buffer
      • 5.2.3.3. Assay Kits
      • 5.2.3.4. Consumables
    • 5.2.4. Market Attractiveness Analysis: Product Type
  • 5.3. Global Molecular Diagnostics Market Outlook: Disease Area
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
      • 5.3.3.1. Infectious Disease
      • 5.3.3.2. Diabetes
      • 5.3.3.3. Cardiology
      • 5.3.3.4. Oncology
      • 5.3.3.5. Nephrology
      • 5.3.3.6. Autoimmune Disease
      • 5.3.3.7. Dermatology
      • 5.3.3.8. Wound Care
      • 5.3.3.9. Others
    • 5.3.4. Market Attractiveness Analysis: Disease Area
  • 5.4. Global Molecular Diagnostics Market Outlook: End-use
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
      • 5.4.3.1. Hospitals & Clinics
      • 5.4.3.2. Diagnostics Laboratories
      • 5.4.3.3. Academic and Research Institutes
      • 5.4.3.4. Biopharmaceutical Companies
    • 5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 7.4.1. Instruments
      • 7.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 7.4.1.4. Microarrays
    • 7.4.2. Reagent
      • 7.4.2.1. Antibodies
      • 7.4.2.2. DNA Template
      • 7.4.2.3. DNA Polymerase
      • 7.4.2.4. Oligonucleotide Primers
      • 7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 7.4.2.6. Buffer
    • 7.4.3. Assay Kits
    • 7.4.4. Consumables
  • 7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 7.5.1. Infectious Disease
    • 7.5.2. Diabetes
    • 7.5.3. Cardiology
    • 7.5.4. Oncology
    • 7.5.5. Nephrology
    • 7.5.6. Autoimmune Disease
    • 7.5.7. Dermatology
    • 7.5.8. Wound Care
    • 7.5.9. Others
  • 7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostics Laboratories
    • 7.6.3. Academic and Research Institutes
    • 7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 8.4.1. Instruments
      • 8.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 8.4.1.4. Microarrays
    • 8.4.2. Reagent
      • 8.4.2.1. Antibodies
      • 8.4.2.2. DNA Template
      • 8.4.2.3. DNA Polymerase
      • 8.4.2.4. Oligonucleotide Primers
      • 8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 8.4.2.6. Buffer
    • 8.4.3. Assay Kits
    • 8.4.4. Consumables
  • 8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 8.5.1. Infectious Disease
    • 8.5.2. Diabetes
    • 8.5.3. Cardiology
    • 8.5.4. Oncology
    • 8.5.5. Nephrology
    • 8.5.6. Autoimmune Disease
    • 8.5.7. Dermatology
    • 8.5.8. Wound Care
    • 8.5.9. Others
  • 8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostics Laboratories
    • 8.6.3. Academic and Research Institutes
    • 8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 9.4.1. Instruments
      • 9.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 9.4.1.4. Microarrays
    • 9.4.2. Reagent
      • 9.4.2.1. Antibodies
      • 9.4.2.2. DNA Template
      • 9.4.2.3. DNA Polymerase
      • 9.4.2.4. Oligonucleotide Primers
      • 9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 9.4.2.6. Buffer
    • 9.4.3. Assay Kits
    • 9.4.4. Consumables
  • 9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 9.5.1. Infectious Disease
    • 9.5.2. Diabetes
    • 9.5.3. Cardiology
    • 9.5.4. Oncology
    • 9.5.5. Nephrology
    • 9.5.6. Autoimmune Disease
    • 9.5.7. Dermatology
    • 9.5.8. Wound Care
    • 9.5.9. Others
  • 9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostics Laboratories
    • 9.6.3. Academic and Research Institutes
    • 9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 10.4.1. Instruments
      • 10.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 10.4.1.4. Microarrays
    • 10.4.2. Reagent
      • 10.4.2.1. Antibodies
      • 10.4.2.2. DNA Template
      • 10.4.2.3. DNA Polymerase
      • 10.4.2.4. Oligonucleotide Primers
      • 10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 10.4.2.6. Buffer
    • 10.4.3. Assay Kits
    • 10.4.4. Consumables
  • 10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 10.5.1. Infectious Disease
    • 10.5.2. Diabetes
    • 10.5.3. Cardiology
    • 10.5.4. Oncology
    • 10.5.5. Nephrology
    • 10.5.6. Autoimmune Disease
    • 10.5.7. Dermatology
    • 10.5.8. Wound Care
    • 10.5.9. Others
  • 10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostics Laboratories
    • 10.6.3. Academic and Research Institutes
    • 10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 11.4.1. Instruments
      • 11.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 11.4.1.4. Microarrays
    • 11.4.2. Reagent
      • 11.4.2.1. Antibodies
      • 11.4.2.2. DNA Template
      • 11.4.2.3. DNA Polymerase
      • 11.4.2.4. Oligonucleotide Primers
      • 11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 11.4.2.6. Buffer
    • 11.4.3. Assay Kits
    • 11.4.4. Consumables
  • 11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 11.5.1. Infectious Disease
    • 11.5.2. Diabetes
    • 11.5.3. Cardiology
    • 11.5.4. Oncology
    • 11.5.5. Nephrology
    • 11.5.6. Autoimmune Disease
    • 11.5.7. Dermatology
    • 11.5.8. Wound Care
    • 11.5.9. Others
  • 11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostics Laboratories
    • 11.6.3. Academic and Research Institutes
    • 11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 12.4.1. Instruments
      • 12.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 12.4.1.4. Microarrays
    • 12.4.2. Reagent
      • 12.4.2.1. Antibodies
      • 12.4.2.2. DNA Template
      • 12.4.2.3. DNA Polymerase
      • 12.4.2.4. Oligonucleotide Primers
      • 12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 12.4.2.6. Buffer
    • 12.4.3. Assay Kits
    • 12.4.4. Consumables
  • 12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 12.5.1. Infectious Disease
    • 12.5.2. Diabetes
    • 12.5.3. Cardiology
    • 12.5.4. Oncology
    • 12.5.5. Nephrology
    • 12.5.6. Autoimmune Disease
    • 12.5.7. Dermatology
    • 12.5.8. Wound Care
    • 12.5.9. Others
  • 12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 12.6.1. Hospitals & Clinics
    • 12.6.2. Diagnostics Laboratories
    • 12.6.3. Academic and Research Institutes
    • 12.6.4. Biopharmaceutical Companies

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Becton, Dickinson and Company
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Bio-Rad Laboratories In
    • 13.3.3. Merck KgaA
    • 13.3.4. Thermo Fisher Scientific Inc
    • 13.3.5. Agilent Technologies, Inc.
    • 13.3.6. F. Hoffman - La Roche Ltd.
    • 13.3.7. Illumina, Inc.
    • 13.3.8. Qiagen N.V.
    • 13.3.9. Hologic Inc.
    • 13.3.10. Siemens Healthineers AG
    • 13.3.11. Seegene, Inc.
    • 13.3.12. DiaSorin S.p.A
    • 13.3.13. Grifols, S.A.
    • 13.3.14. bioMerieux
    • 13.3.15. QuidelOrtho Corporation

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations